Pentwater Capital (NASDAQ: CORZ) discloses 1.34M-share Core Scientific position
Rhea-AI Filing Summary
Pentwater Capital Management LP and Matthew Halbower report beneficial ownership of Core Scientific, Inc. common stock on a Schedule 13G/A. They collectively report 1,336,594 shares of Common Stock, including 800,000 shares issuable upon exercise of options, representing 0.4% of the class based on 317,885,292 shares outstanding as of May 1, 2026. All voting and dispositive authority over these shares is reported as shared, with no sole voting or dispositive power.
Positive
- None.
Negative
- None.
Key Figures
Shares beneficially owned: 1,336,594 shares
Ownership percentage: 0.4 %
Shares outstanding: 317,885,292 shares
+2 more
5 metrics
Shares beneficially owned
1,336,594 shares
Common Stock beneficially owned by the Reporting Persons
Ownership percentage
0.4 %
Percent of Core Scientific Common Stock class owned by Reporting Persons
Shares outstanding
317,885,292 shares
Core Scientific Common Stock outstanding as of May 1, 2026
Shares issuable upon exercise of options
800,000 shares
Common Stock issuable upon exercise of options included in beneficial ownership
Shared voting power
1,336,594 shares
Shares over which Reporting Persons have shared voting power
Key Terms
beneficial owner, shared voting power, dispositive power, Schedule 13G
4 terms
beneficial owner financial
"beneficial owner of the securities reported herein"
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
dispositive power financial
"Shared Dispositive Power 1,336,594.00"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
Schedule 13G regulatory
"for the purposes of Section 13 of the Securities and Exchange Act of 1934"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
FAQ
What stake in Core Scientific (CORZ) does Pentwater Capital report in this Schedule 13G/A?
Pentwater Capital Management and Matthew Halbower report beneficial ownership of 1,336,594 Core Scientific shares, representing 0.4% of the outstanding Common Stock, including 800,000 shares issuable upon exercise of options held by Pentwater funds.
Who are the reporting persons in this Core Scientific (CORZ) Schedule 13G/A filing?
The reporting persons are Pentwater Capital Management LP, a Delaware limited partnership investment adviser to certain funds, and Matthew Halbower, a U.S. citizen and sole shareholder of MCH PWCM Holdings Inc., the general partner of the Investment Manager.
What portion of Pentwater’s reported Core Scientific (CORZ) position comes from options?
The filing states that the reported position includes 800,000 shares of Common Stock issuable upon exercise of options directly held by Pentwater funds, which form a substantial part of the total 1,336,594 shares reported as beneficially owned.
AI-generated analysis. How Rhea-AI works. Not financial advice.